A proposed fund to compensate victims of a nationwide meningitis outbreak linked to a Massachusetts pharmacy has been increased by about $35 million.

The outbreak, blamed on a tainted steroid produced by Framingham-based New England Compounding Center, sickened more than 750 people in 20 states, according to the Centers for Disease Control and Prevention. Sixty-four people died.

Court-appointed bankruptcy trustee Paul Moore said in a statement that a new agreement filed Wednesday with the U.S. Bankruptcy Court in Massachusetts calls for a fund of at least $135 million to compensate people who were injured and relatives of those who died.

An earlier settlement announced in May called for a more than $100 million fund, including $50 million from the owners of the now-defunct company.

Judge Henry Boroff must still approve the plan.